Codes / ICD10CM / M84.559A

M84.559A Pathological fracture in neoplastic disease, hip, unspecified, initial encounter for fracture

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Pathological Fracture in Neoplastic Disease, Hip, Unspecified, Initial Encounter for Fracture (ICD-10-CM: M84.559A)

Summary

This condition describes a bone fracture occurring due to underlying neoplastic (cancerous) disease, specifically involving the hip. The fracture results from weakened bone structure caused by the presence of cancer, rather than direct trauma. It is a complication of malignancy affecting the hip's bone integrity, which may involve primary bone tumors or metastatic spread to the hip region. This code is used for the initial encounter when the fracture is diagnosed.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the hip, compromising its structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode hip bone, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

  • History of cancer, particularly with known bone metastasis to the hip.
  • Advanced-stage malignancies with skeletal involvement.
  • Tumors that preferentially affect bone (e.g., multiple myeloma).
  • Prior radiation therapy to hip sites.
  • Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

  • Sudden onset of pain at the fracture site, often severe and unrelieved by rest.
  • Swelling, bruising, or deformity around the hip.
  • Inability to bear weight or move the affected leg.
  • Limited range of motion in the hip joint.
  • Possible numbness or tingling if nerve involvement occurs.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. A thorough patient history, including cancer history, is essential. Imaging studies such as X-rays, CT scans, or MRI are used to visualize the fracture and assess bone integrity. Bone scans may identify other areas of metastasis. Biopsy of the affected bone or adjacent tissue may be performed to confirm the underlying neoplastic cause. Laboratory tests, including tumor markers or blood work, may support the diagnosis.

Treatment Options

Treatment focuses on stabilizing the fracture, managing pain, and addressing the underlying cancer. Options include surgical fixation (e.g., pins, plates, or rods) to restore bone stability. Radiation therapy or systemic treatments (e.g., chemotherapy, targeted therapy) may be used to control the neoplastic disease. Pain management with analgesics, including opioids, is often necessary. Rehabilitation, including physical therapy, may aid in recovery and mobility.

Prognosis and Follow-Up

Prognosis depends on the extent of the underlying cancer, the fracture's severity, and the patient's overall health. Fractures in advanced cancer may have a guarded prognosis due to limited healing capacity. Follow-up includes regular imaging to monitor bone healing and cancer progression. Pain management and mobility support are ongoing considerations. Multidisciplinary care involving oncologists, orthopedic surgeons, and pain specialists is typical.

Complications

  • Delayed or nonunion of the fracture due to compromised bone healing.
  • Infection at the fracture site or surgical site.
  • Nerve damage or vascular injury from the fracture or treatment.
  • Progression of the underlying cancer, leading to further bone destruction.
  • Chronic pain or reduced mobility affecting quality of life.

Lifestyle & Prevention

  • Maintain bone health through adequate calcium and vitamin D intake, if appropriate.
  • Engage in weight-bearing exercises to strengthen bones, as advised by a healthcare provider.
  • Avoid high-impact activities that increase fracture risk, especially with known bone weakness.
  • Follow cancer treatment plans to control the underlying disease and reduce bone damage.
  • Use assistive devices (e.g., walkers, canes) to prevent falls and protect the hip.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden, severe hip pain, inability to move the leg, or visible deformity. Contact a healthcare provider promptly if pain worsens, swelling increases, or new symptoms (e.g., numbness) develop. Regular follow-up is essential for those with a history of cancer to monitor for potential fractures.

Tips for Medical Coders

This code (M84.559A) is specific to a pathological fracture in neoplastic disease of the hip, unspecified, during the initial encounter. Documentation should clearly indicate the fracture's location (hip), the underlying neoplastic cause, and that this is the first encounter for the fracture. Ensure the fracture is not attributed to trauma and that the hip is not further specified (e.g., left/right) to align with the code's specificity. Verify that the encounter type (initial) is appropriately documented to support accurate coding.

Book a walkthrough

M84.559A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.